Synthesis and antiproliferative evaluation of amide-containing anthraquinone, xanthone, and carbazole

Chemical and Pharmaceutical Bulletin

Volumn 62, Issue 1, 2014, Pages 106-111

  Chen, Li Chai ^a   Juang, Shin Hun ^b,c   Chang, Ken Ming ^d   Tzeng, Cherng Chyi ^d   Chen, Jih Jung ^e   Chen, I Li ^e   Wang, Tai Chi ^e  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e TAJEN UNIVERSITY   (Taiwan)

Author keywords

Anthraquinone; Antiproliferative activity; Carbazole; Nasopharyngeal carcinoma (NPC); Xanthone

Indexed keywords

2 (9,10 DIOXO 9,10 DIHYDROANTHRACEN 2 YLOXY) N (4 FLUOROPHENYL)ACETAMIDE; 2 (9,10 DIOXO 9,10 DIHYDROANTHRACEN 2 YLOXY) N (4 METHOXYPHENYL)ACETAMIDE; 2 (9,10 DIOXO 9,10 DIHYDROANTHRACEN 2 YLOXY) N (NAPHTHALEN 2 YL)ACETAMIDE; 2 (9,10 DIOXO 9,10 DIHYDROANTHRACEN 2 YLOXY) N PHENYLACETAMIDE; 2 (9H CARBAZOL 2 YLOXY) N (4 FLUOROPHENYL)ACETAMIDE; 2 (9H CARBAZOL 2 YLOXY) N (4 METHOXYPHENYL)ACETAMIDE; 2 (9H CARBAZOL 2 YLOXY) N (BIPHENYL 4 YL)ACETAMIDE; 2 (9H CARBAZOL 2 YLOXY) N PHENYLACETAMIDE; ACETAMIDE DERIVATIVE; AMIDE; ANTHRAQUINONE DERIVATIVE; CARBAZOLE DERIVATIVE; DIBENZOFURAN DERIVATIVE; N (4 FLUOROPHENYL) 2 (9 OXO 9H XANTHEN 3 YLOXY)ACETAMIDE; N (4 METHOXYPHENYL) 2 (9 OXO 9H XANTHEN 3 YLOXY)ACETAMIDE; N (BIPHENYL 4 YL) 2 (9 OXO 9H XANTHEN 3 YLOXY)ACETAMIDE; N (DIPHENYL 4 YL) 2 (9,10 DIOXO 9,10 DIHYDROANTHRACEN 2 YLOXY)ACETAMIDE; N (NAPHTHALEN 2 YL) 2 (9 OXO 9H XANTHEN 3 YLOXY)ACETAMIDE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEUKEMIA CELL; LUNG CARCINOMA; NASOPHARYNX CARCINOMA;

AMIDES; ANTHRAQUINONES; CARBAZOLES; CELL LINE, TUMOR; CELL PROLIFERATION; G0 PHASE; G1 PHASE; HUMANS; XANTHONES;

EID: 84892166105     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c13-00617     Document Type: Article

References (17)

1. Hsu M. M., Tu S. M., Cancer, 52, 362-368 (1983).
2. Altun M., Fandi A., Dupuis O., Cvitkovic E., Krajina Z., Eschwege F., Int. J. Radiat. Oncol. Biol. Phys., 32, 859-877 (1995).
3. Niedobitek G., Mol. Pathol., 53, 248-254 (2000).
4. Fang W., Li X., Jiang Q., Liu Z., Yang H., Wang S., Xie S., Liu Q., Liu T., Huang J., Xie W., Li Z., Zhao Y., Wang E., Marincola F. M., Yao K., J. Transl. Med., 6, 32 (2008).
5. Chang E. T., Adami H. O., Cancer Epidemiol. Biomarkers Prev., 15, 1765-1777 (2006).
6. Chan A. T., Teo P. M., Leung T. W., Johnson P. J., Cancer, 82, 1003-1012 (1998).
7. Hsu C. H., Chen C. L., Hong R. L., Chen K. L., Lin J. F., Cheng A. L., Oncology, 62, 305-312 (2002).
8. Wang T. C., Zhao Y. L., Kuo D. H., Eur. J. Med. Chem., 36, 909-914 (2001).
9. Wang T. C., Chen Y. L., Tzeng C. C., Liou S. S., Tzeng W. F., Chang Y. L., Teng C. M., Helv. Chim. Acta, 81, 1038-1047 (1998).
10. Chen L. C., Chen I. L., Huang C. C., Liao C. H., Chen J. Y., Wang T. C., J. Chin. Chem. Soc. (Taipei), 57, 1331-1340 (2010).
11. Tzeng C. C., Chen I. L., Chen Y. L., Wang T. C., Chang Y. L., Teng C. M., Helv. Chim. Acta, 83, 349-358 (2000).
12. Wang T. C., Chen I. L., Lu C. M., Kuo D. H., Liao C. H., Chem. Biodivers., 2, 253-263 (2005).
13. Wang T. C., Chen I. L., Kuo D. H., Liao C. H., Helv. Chim. Acta, 87, 983-990 (2004).
14. Chen I. L., Chang K. M., Miaw C. L., Liao C. H., Chen J. J., Wang T. C., Bioorg. Med. Chem., 15, 6527-6534 (2007).
15. Chen I. L., Chen J. Y., Shieh P. C., Chen J. J., Lee C. H., Juang S. H., Wang T. C., Bioorg. Med. Chem., 16, 7639-7645 (2008).
16. Chen I. L., Chen J. J., Lin Y. C., Peng C. T., Juang S. H., Wang T. C., Eur. J. Med. Chem., 59, 227-234 (2013).
17. Hansen M. B., Nielsen S. E., Berg K., J. Immunol. Methods, 119, 203-210 (1989).